Arvee Laboratories (India) LtdNSE ARVEE

Arvee Laboratories (India) Ltd. provides chemical products, which includes polymer modifiers, contrast media and drug intermediates. The company is headquartered in Ahmedabad, Gujarat and currently employs 67 full-time employees. The company went IPO on 2018-02-22. The firm's product categories include polymer modifiers, contrast media intermediates and drug intermediates. Its polymer modifiers products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt and 5-Sodiosulfo-Bis-(B-Hydroxyethyl)-Isophthalate. The firm's contrast media intermediates products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, and 3,5-Diamino Benzoic Acid. Its drug intermediates products include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.